Application Note: Accelerated antibody discovery application compendium
10 November 2020
Monoclonal antibodies (mAbs) still remain a focus of biopharma research. In the discovery process, you need to make crucial decisions, such as selecting your best clones and identifying your best drug candidates. This can be challenging, especially when using traditional screening methods.